Magnetic resonance imaging technique for tissue characterization

• US 5,671,741 A
• Filed: 08/04/1995
• Issued: 09/30/1997
• Est. Priority Date: 08/04/1995
• Status: Expired due to Fees

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Wendland, Michael, Gindele, Alexander, Lang, Philipp, Saeed, Maythem
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): MANTIS MERCADER, ELENI M
• Application Number:
  US08/511,286
• Time in Patent Office: 788 Days
• Field of Search: 128/653.2, 324/307, 324/309
• US Class Current: 600/415
• CPC Class Codes: G01R 33/5608 Data processing and visualization specially adapted for MR, e.g. for feature analysis and pattern recognition on the basis of measured MR data, segmentation of measured MR data, edge contour detection on the basis of measured MR data, for enhancing measured MR data in terms of signal-to-noise ratio by means of noise filtering or apodization, for enhancing measured MR data in terms of resolution by means for deblurring, windowing, zero filling, or generation of gray-scaled images, colour-coded images or images displaying vectors instead of pixels image data processing or generation, in general G06T
• CPC Class Codes: G01R 33/56341 Diffusion imaging

Abstract

An in vivo diagnostic method for differentiating normal from diseased tissue is described, using diffusion-weighted magnetic resonance imaging (MRI). Differences in molecular diffusion between viable and necrotic tissue, and normal and diseased tissue, are measured using diffusion-weighted MRI techniques to evaluate the success of a medical treatment regimen.

Claims

1. A diagnostic method for differentiating necrotic from viable tissue in vivo, comprising the steps of:

a. providing a patient having a region of diseased tissue;

b. placing said region within a constant external magnetic field;

c. applying at least one diffusion-weighted magnetic resonance imaging technique to said region; and

d. differentiating necrotic from viable tissue based on magnetic resonance signals produced by said imaging technique.

2. The method of claim 1, wherein said magnetic resonance signals are used to calculate diffusion coefficients for said region, and said diffusion coefficients are used to differentiate necrotic from viable tissue in said region.

3. The method of claim 1, wherein said patient is a patient with a neoplastic disease and said diseased tissue is tumor tissue.

4. The method of claim 1, wherein said patient is a patient with an inflammatory disease, and said diseased tissue is inflamed tissue.

5. The method of claim 1, wherein said patient is a patient with an infectious disease, and said diseased tissue is infected tissue.

6. The method of claim 1, wherein said region of diseased tissue is selected from the group comprising:

the neck, the chest and cardiovascular system, the abdomen, pelvis and all internal organs, and the musculoskeletal system including the spine, the axial skeleton, the arms and the legs.

7. The method of claim 1, wherein said diffusion-weighted magnetic resonance imaging technique comprises a diffusion-weighted spin-echo pulse sequence.

8. The method of claim 1, wherein said diffusion-weighted magnetic resonance imaging technique comprises a diffusion-weighted gradient-echo pulse sequence.

9. The method of claim 1, wherein said diffusion-weighted magnetic resonance imaging technique comprises a diffusion-weighted stimulated echo pulse sequence.

10. A clinical method for evaluating the efficacy of a medical treatment, comprising the steps of:

a. providing a patient undergoing medical treatment having a region of diseased tissue;

said region selected from the group comprising;

the neck, the chest and cardiovascular system, the abdomen, pelvis and all internal organs, and the musculoskeletal system including the spine, the axial skeleton, the arms and the legs;

b. placing said region within a constant external magnetic field;

c. applying at least one diffusion-weighted spin-echo pulse sequence to said region; and

d. differentiating necrotic from viable tissue based on magnetic resonance signals produced by said diffusion-weighted spin-echo pulse sequence, and diffusion coefficients of said region of diseased tissue calculated therefrom, so as to evaluate the efficacy of said medical treatment.

11. The method of claim 10, wherein said patient is a patient with a neoplastic disease and said diseased tissue is tumor tissue.

12. The method of claim 11, wherein said neoplastic disease is gastrointestinal cancer.

13. The method of claim 11, wherein said neoplastic disease is pancreatic cancer.

14. The method of claim 11, wherein said neoplastic disease is colon cancer.

15. The method of claim 11, wherein said neoplastic disease is melanoma.

16. The method of claim 11, wherein said neoplastic disease is lung cancer.

17. The method of claim 11, wherein said neoplastic disease is a musculoskeletal neoplasm.

18. The method of claim 10, wherein said patient is a patient with an inflammatory disease, and said diseased tissue is inflamed tissue.

19. The method of claim 10, wherein said patient is a patient with an infectious disease, and said diseased tissue is infected tissue.

20. A diagnostic method for differentiating necrotic from viable tissue in vivo, comprising the steps of:

a. providing a patient having a suspected region of necrotic tissue;

b. placing said suspected region within a constant external magnetic field;

c. applying at least one diffusion-weighted magnetic resonance imaging technique to said suspected region; and

d. differentiating necrotic from viable tissue based on magnetic resonance signals produced by said imaging technique, wherein said magnetic resonance signals are used to calculate diffusion coefficients, and said diffusion coefficients are used to differentiate necrotic from viable tissue in said suspected region.

21. The method of claim 20, wherein said suspected region is selected from the group comprising:

the neck, the chest and cardiovascular system, the abdomen, pelvis and all internal organs, and the musculoskeletal system including the spine, the axial skeleton, the arms and the legs.

22. The method of claim 20, wherein said diffusion-weighted magnetic resonance imaging technique comprises a diffusion-weighted spin-echo pulse sequence.

23. The method of claim 20, wherein said diffusion-weighted magnetic resonance imaging technique comprises a diffusion-weighted gradient-echo pulse sequence.

24. The method of claim 20, wherein said diffusion-weighted magnetic resonance imaging technique comprises a diffusion-weighted stimulated echo pulse sequence.

25. The method of claim 20, wherein said necrotic tissue comprises cancer tissue.